Related references
Note: Only part of the references are listed.Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer
Yan Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
BTLA mediates inhibition of human tumor-specific CD8(+) T cells that can be partially reversed by vaccination
Laurent Derre et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells
Kim L. Good-Jacobson et al.
NATURE IMMUNOLOGY (2010)
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
Junko Matsuzaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway
Kathrin Gollmer et al.
BLOOD (2009)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas
Sebastian Attig et al.
CANCER RESEARCH (2009)
Reviving Function in CD4+ T Cells Adapted to Persistent Systemic Antigen
Magali Noval Rivas et al.
JOURNAL OF IMMUNOLOGY (2009)
PD-1 Is a Regulator of NY-ESO-1-Specific CD8+ T Cell Expansion in Melanoma Patients
Julien Fourcade et al.
JOURNAL OF IMMUNOLOGY (2009)
Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells
Emmanuelle Fourmentraux-Neves et al.
BLOOD (2008)
Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes
Nathalie Demotte et al.
IMMUNITY (2008)
Signaling defects in anti-tumor T cells
Alan B. Frey et al.
IMMUNOLOGICAL REVIEWS (2008)
The sound of silence: modulating anergy in T lymphocytes
Samuel D. Sabil et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs
Raymond M. Wong et al.
INTERNATIONAL IMMUNOLOGY (2007)
Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers
Juro Nakanishi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
CCR7 ligands control basal T cell motility within lymph node slices in a phosphoinositide 3-kinase independent manner
Francois Asperti-Boursin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma
R. Houston Thompson et al.
CLINICAL CANCER RESEARCH (2007)
Membrane-associated TGF-β1 inhibits human memory T cell signaling in malignant and nonmalignant inflammatory microenvironments
Lori Broderick et al.
JOURNAL OF IMMUNOLOGY (2006)
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up
RH Thompson et al.
CANCER RESEARCH (2006)
Adaptive tolerance and clonal anergy are distinct biochemical states
L Chiodetti et al.
JOURNAL OF IMMUNOLOGY (2006)
IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells
L Broderick et al.
CLINICAL IMMUNOLOGY (2006)
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
V Bronte et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
TGF-β signaling and the fibrotic response
A Leask et al.
FASEB JOURNAL (2004)
Effector function of human tumor-specific CD8 T cells in melanoma lesions:: A state of local functional tolerance
A Zippelius et al.
CANCER RESEARCH (2004)
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
JM Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2004)
Advances in the treatment of leishmaniasis
S Sundar et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2002)
Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes
I Stefanová et al.
NATURE (2002)
Transcriptional mechanisms underlying lymphocyte tolerance
F Macián et al.
CELL (2002)
Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines
MK Pathak et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
